BACKGROUND AND PURPOSE:We investigated the relationship between tumor blood-flow measurement based on perfusion imaging by arterial spin-labeling (ASL-PI) and histopathologic findings in brain tumors.

BACKGROUND AND PURPOSE: MSDE preparation is a technique for black-blood imaging. Our purpose was to evaluate the usefulness of a 3D TSE sequence with MSDE preparation in detecting brain metastases by comparing it with conventional sequences.

BACKGROUND AND PURPOSE:Cerebral hemodynamics abnormality in Alzheimer disease (AD) is not fully understood. Our aim was to determine whether regional hypoperfusion due to AD is associated with abnormalities in regional arterial blood volume (rABV) and regional arterial transit time (rATT) as measured by quantitative arterial spin-labeling (ASL) with multiple-delay time sampling.

No abstract

The purpose of this study was to determine whether arterial spin labelling (ASL) at 3-T MR imaging can be used to discriminate individuals with Alzheimer's disease (AD) from cognitively normal subjects. Twenty AD patients and 23 cognitively normal control subjects were studied using ASL on a 3-T MR imager. Absolute regional cerebral blood flow (rCBF) maps were calculated. In addition, normalized rCBF maps were obtained using CBF in the sensorimotor cortex for normalization. A voxel-wise comparison of these rCBF maps between the AD and control groups was performed using the two-sample t test. Individuals with AD were discriminated from control subjects based on mean rCBF values within a region-of-interest defined by the t test, and the discriminating performance was evaluated by the receiver operating characteristic (ROC) analysis. Comparisons of both absolute and normalized rCBF maps revealed areas of significant hypoperfusion caused by the effects of AD in the bilateral precunei and posterior cingulate gyri. ROC analyses resulted in area under the curve (AUC) values of 0.861 to 0.877 for absolute and 0.910 to 0.932 for normalized rCBF. Our results suggest that ASL at 3-T MR imaging can be used to help discriminate individuals with AD from normal subjects.